Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Interventional Spine, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

80 daysmedian FDA review time
248 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K160464Opticage(R) Expandable Interbody Fusion DeviceInterventional Spine, Inc.2016-04-04452
K152156Opticage Expandable Interbody Fusion DeviceInterventional Spine, Inc.2015-10-19772
K140716OPTICAGE EXPANDABLE INTERBODY FUSION DEVICEInterventional Spine, Inc.2014-11-242480
K133583OPTICAGE INTERBODY FUSION DEVICE, MODEL SERIES 9070Interventional Spine, Inc.2014-02-10810
K132479OPTICAGE INTERBODY FUSION DEVICE, MODEL 9080-00Interventional Spine, Inc.2013-09-19420
K113527OPTICAGE INTERBODY FUSION DEVICEInterventional Spine, Inc.2012-01-20510
K090767PERPOS FCD-2 SYSTEM (SINGLE PATIENT USE), ANCHOR, STABILIZERInterventional Spine, Inc.2009-06-11800
K082795SINGLE USE PERPOS PLS SYSTEM, 4.5 BONE-LOK PLS IMPLANTInterventional Spine, Inc.2008-12-12800

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda